Propel Bio Management, LLC Diversified Active

Location: Los Angeles, CA

CIK: 0001969764 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $86.07M (100.0% shares, 0.0% debt)

Holdings (18)

PAGP PLAINS GP HOLDINGS LP-CL 31.6%
Value $27.18M Shares 1,272,360 Est. Cost $18.82 Unrealized
MDGL MADRIGAL PHARMACEUTICALS 11.6%
Value $9.947M Shares 30,032 Est. Cost $193.31 Unrealized +70.0%
AKERO THERAPEUTICS INC 10.8%
Value $9.265M Shares 228,884 Est. Cost $24.86 Unrealized
PHAT PHATHOM PHARMACEUTICALS I 8.3%
Value $7.116M Shares 1,134,927 Est. Cost $8.64 Unrealized -29.8%
ACHV ACHIEVE LIFE SCIENCES INC 7.6%
Value $6.55M Shares 2,453,092 Est. Cost $4.44 Unrealized -29.9%
APPLIED THERAPEUTICS INC 6.4%
Value $5.517M Shares 11,285,420 Est. Cost $2.53 Unrealized
RNAM AVIDITY BIOSCIENCES INC 6.1%
Value $5.269M Shares 178,500 Est. Cost $6.68 Unrealized +365.9%
ABEO ABEONA THERAPEUTICS INC 3.5%
Value $2.97M Shares 624,022 Est. Cost $5.10 Unrealized +6.6%
TCRX TSCAN THERAPEUTICS INC 3.3%
Value $2.88M Shares 2,087,139 Est. Cost $4.58 Unrealized -52.8%
DCTH DELCATH SYSTEMS INC 2.6%
Value $2.261M Shares 177,600 Est. Cost $13.84 Unrealized +2.5%
SNDX SYNDAX PHARMACEUTICALS IN 2.6%
Value $2.251M Shares 183,259 Est. Cost $20.44 Unrealized -31.0%
ZVRA ZEVRA THERAPEUTICS INC 1.6%
Value $1.347M Shares 179,874 Est. Cost $6.78 Unrealized +17.2%
MIST MILESTONE PHARMACEUTICALS 1.3%
Value $1.161M Shares 1,451,557 Est. Cost $1.99 Unrealized 0.0%
MATPF MAAT PHARMA SACA 1.2%
Value $1.038M Shares 166,423 Est. Cost $6.26 Unrealized
CMPX COMPASS THERAPEUTICS INC 0.5%
Value $434K Shares 228,317 Est. Cost $2.66 Unrealized 0.0%
ATHIRA PHARMA INC 0.5%
Value $425K Shares 1,492,792 Est. Cost $2.43 Unrealized
EIGER BIOPHARMACEUTICALS 0.5%
Value $423K Shares 146,381 Est. Cost $5.00 Unrealized
CHINOOK THERAPEUTICS 0.0%
Value $38,500 Shares 79,357 Est. Cost Unrealized